Gentibio, Inc
Clinical trials sponsored by Gentibio, Inc, explained in plain language.
-
Personalized cell therapy aims to tame type 1 diabetes in early trial
Disease control Recruiting nowThis early-stage study is testing a new treatment called GNTI-122 for adults who were recently diagnosed with type 1 diabetes. The therapy is made from a person's own blood cells and is designed to help rebalance the immune system. Sixteen participants will receive either a low o…
Phase: PHASE1 • Sponsor: GentiBio, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Gene hunt in newly diagnosed type 1 diabetes adults
Knowledge-focused Recruiting nowThis study is for adults aged 18 to 55 who were diagnosed with type 1 diabetes within the last 6 months. Researchers want to see how many of them carry a specific gene called HLA-DRB1*04:01. Participants will provide a blood sample or cheek swab for genetic testing. The goal is t…
Sponsor: GentiBio, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC